IP Verse

Biogen Ma patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Biogen Ma opposed by its competitors

Explore Biogen Ma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2645106
Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent1
EP3036320
Apr 3, 2024Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters1
EP2956477
Jan 24, 2024Optimized Factor Viii Gene1
EP3999643
Nov 22, 2023Methods Of Treating Or Preventing Spinal Muscular Atrophy5
EP2701778
Oct 18, 2023A Limiter For A Dispensing Device2
EP2972238
Apr 26, 2023Use Of Raman Spectroscopy To Monitor Culture Medium2
EP3339865
Dec 14, 2022Assay For Jc Virus Antibodies1
EP3575792
Nov 30, 2022Method Of Assessing Risk Of Pml2
EP2653873
Aug 24, 2022Compositions And Uses For Treating Multiple Sclerosis14
EP3122869
Aug 10, 2022Methods For Overcoming Glutamine Deprivation During Mammalian Cell Culture1

Top competitors of Biogen Ma

List of top competitors of Biogen Ma based on patent oppositions.